Identifying Optimal Combinations of Immune-Based Therapies: Metastatic NSCLC – Boston, MA
This program will review current and emerging immunotherapies for the management of patients with advanced NSCLC.
This program will review current and emerging immunotherapies for the management of patients with advanced NSCLC.
Fill out your Evaluation Form
Fill out your Evaluation Form
This program will review current and emerging immunotherapies for the management of patients with advanced NSCLC.
This live virtual activity will cover the care and treatment of patients with moderate to severe atopic dermatitis.
This live, case‐based activity targets health care gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health‐related quality of life through burden of disease and associated comorbidities.
This program will review current and emerging immunotherapies for the management of patients with advanced NSCLC.
This program will review current and emerging immunotherapies for the management of patients with advanced NSCLC.
This program will review current and emerging immunotherapies for the management of patients with advanced NSCLC.
This live virtual activity will cover the care and treatment of patients with moderate to severe atopic dermatitis.
This activity will cover the treatment and management of patients locally-advanced or metastatic urothelial carcinoma.
This live, case‐based activity targets health care gaps related to the underlying autoimmune causes of alopecia areata (AA) and targeted treatment approaches, which can have a profound impact on health‐related quality of life through burden of disease and associated comorbidities.